What is the history of CHARGE Syndrome?

CHARGE syndrome was first described in 1979 by Dr. B.D. Hall and expanded upon in 1981 by Dr. H.M. Hittner, who coined the acronym based on its characteristic clinical features. Our understanding of CHARGE syndrome has evolved from a collection of observed symptoms to a well-defined genetic condition primarily caused by mutations in the CHD7 gene.

How was CHARGE syndrome first identified?

The history of CHARGE syndrome began when clinicians noticed a recurring pattern of congenital anomalies in newborns. In 1981, Dr. Hittner proposed the acronym to represent: Coloboma, Heart defects, Atresia choanae, Retarded growth/development, Genital abnormalities, and Ear anomalies. Initially, it was believed to be a random association of birth defects; however, the medical community soon recognized it as a distinct, recognizable syndrome that required multidisciplinary care.

How has our understanding of the genetics of CHARGE syndrome evolved?

For decades, CHARGE syndrome was diagnosed solely through clinical criteria. A major breakthrough occurred in 2004 when researchers identified that approximately 60-70% of individuals with the clinical features of the condition have a heterozygous mutation in the CHD7 gene on chromosome 8. This discovery transformed the diagnostic process, allowing for definitive molecular confirmation and improved genetic counseling for families.

What are the major milestones in the history of the condition?

The evolution of care for those with CHARGE syndrome has been marked by several significant shifts:

• 1979-1981: Initial clinical characterization and naming of the syndrome.


• 2004: Discovery of the CHD7 gene as the primary cause.


• 2005-Present: Shift toward personalized, multidisciplinary care teams, including ENT specialists, cardiologists, and pediatric therapists.


• Community Growth: The formation of global support networks, including the 122 members now part of the DiseaseMaps.org community, has provided vital patient-reported data.

How did historical misconceptions change?

Early in its history, CHARGE syndrome was often misdiagnosed as other conditions like VACTERL association. As clinicians tracked long-term outcomes, they realized that the "retarded growth" aspect was often secondary to feeding difficulties rather than an inherent developmental ceiling, leading to earlier interventions with G-tubes and specialized therapies.

Next steps

• Consult a clinical geneticist to discuss CHD7 testing if you suspect CHARGE syndrome.


• Connect with the 122 families on DiseaseMaps.org to share experiences and coping strategies.


• Ensure your care team includes specialists in audiology, ophthalmology, and cardiology to manage the multisystem nature of the syndrome.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): CHARGE syndrome.


• Orphanet: Rare Disease Database (ORPHA:166).


• OMIM (Online Mendelian Inheritance in Man): #214800 (CHARGE Syndrome).


• CHARGE Syndrome Foundation: Clinical resources and patient history.